Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 "PembroRad" randomized trial

被引：51

作者：

Bourhis, J. ^{[1
]}

Sire, C. ^{[2
]}

Tao, Y. ^{[3
]}

Martin, L. ^{[4
]}

Alfonsi, M. ^{[5
]}

Prevost, J. B. ^{[6
]}

Rives, M. ^{[7
]}

Lafond, C. ^{[8
]}

Tourani, J. M. ^{[9
]}

Biau, J. ^{[10
]}

Geoffrois, L. ^{[11
]}

Coutte, A. ^{[12
]}

Liem, X. ^{[13
]}

Vauleon, E. ^{[14
]}

Drouet, F. ^{[15
]}

Pechery, A. ^{[16
]}

Guigay, J. ^{[17
]}

Wanneveich, M. ^{[16
]}

Auperin, A. ^{[3
]}

Sun, X. ^{[18
]}

机构：

[1] CHU Vaudois, Radiat Oncol, Lausanne, Switzerland

[2] CHU Bretagne Sud, Lorient, France

[3] Inst Gustave Roussy, Radiat Oncol, Villejuif, France

[4] Clin Ormeaux, Le Havre, France

[5] Inst St Catherine, Avignon, France

[6] Ctr Pierre Curie, Beuvry, France

[7] Inst Claudius Regaud, Toulouse, France

[8] Clin Victor Hugo, Le Mans, France

[9] CHU Poitiers, Hop Jean Bernard, Poitiers, France

[10] Ctr Lutte Canc J Perrin, Clermont Ferrand, France

[11] Inst Cancerol Lorraine Alexis Vautrin, Med Oncol, Vandoeuvre Les Nancy, France

[12] CHU Amiens Picardie Site Sud, Radiat Oncol, Amiens, France

[13] Ctr Oscar Lambret, Radiotherapy, Lille, France

[14] Ctr Eugene Marquis, Rennes, France

[15] Clin Mutualiste Estuaire, St Nazaire, France

[16] CHU Bretonneau, GORTEC, Tours, France

[17] Ctr Anticanc Antoine Lacassagne, Med Oncol Dept, Nice, France

[18] Hop Nord Franche Comte, Belfort, France

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.2268

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA38

引用

页码：S1168 / S1168

页数：1

共 50 条

[1] A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 "PembroRad" trial.
Sun, Xu Shan
Sire, Christian
Tao, Yungan
Martin, Laurent
Alfonsi, Marc
Prevost, Jean Briac
Rives, Michel
Lafond, Cedrik
Tourani, Jean-Marc
Biau, Julian
Geoffrois, Lionnel
Coutte, Alexandre
Liem, Xavier
Vauleon, Elodie
Drouet, Franck
Ramee, Jean-Francois
Waksi, Gabriel
Sinigaglia, Laura
Auperin, Anne
Bourhis, Jean
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Tao, Y.
Biau, J.
Sun, X. S.
Sire, C.
Martin, L.
Alfonsi, M.
Prevost, J. B.
Modesto, A.
Lafond, C.
Tourani, J. M.
Miroir, J.
Kaminsky, M. C.
Coutte, A.
Liem, X.
Chautard, E.
Vauleon, E.
Drouet, F.
Ruffer, A.
Ramee, J. F.
Waksi, G.
Pechery, A.
Wanneveich, M.
Guigay, J.
Auperin, A.
Bourhis, J.
ANNALS OF ONCOLOGY, 2023, 34 (01) : 101 - 110
[3] Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial
Borel, C.
Sun, X.
Coutte, A.
Bera, G.
Zanetta, S.
Alfonsi, M.
Janoray, G.
Chatellier, T.
Garcia-Ramirez, M.
Gherga, E.
Hammoud, Y.
Etienne-Selloum, N.
Pechery, A.
Girard-Calais, M. H.
Velten, M.
Pignon, J-P.
Wanneveich, M.
Bourhis, J.
ANNALS OF ONCOLOGY, 2020, 31 : S660 - S660
[4] Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapy
Sheth, S.
Bauman, J. R.
Deal, A.
Chera, B.
Shen, C.
Galloway, T.
Hackman, T.
Blumberg, J.
Yarbrough, W.
Weissler, M.
Hilliard, C.
Mehra, R.
Grilley-Olson, J.
Weiss, J.
ANNALS OF ONCOLOGY, 2019, 30
[5] Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH)
Tao, Yungan
Auperin, Anne
Sun, Xu Shan
Sire, Christian
Martin, Laurent
Bera, G.
Coutte, Alexandre
Miroir, Jessica
Lafond, Cedrik
Colin-Batailhou, Natacha
Maillard, Aline
Gibel, Laurent
Michel, Cecile
Guigay, Joel
Bourhis, Jean
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[6] KEYNOTE-412: Pembrolizumab (pembro) in combination with chemoradiation versus chemoradiation alone in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Machiels, Jean -Pascal H.
Licitra, Lisa
Rischin, Danny
Waldron, John
Burtness, Barbara
Gregoire, Vincent
Shekar, Tulin
Brown, Holly M.
Cheng, Jonathan D.
Siu, Lillian L.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[7] Avelumab-cetuximab-radiotherapy (RT) versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Final analysis of randomized phase III GORTEC 2017-01 REACH trial
Tao, Y.
Auperin, A.
Sun, X.
Liem, X.
Sire, C.
Martin, L.
Pointreau, Y.
Borel, C.
Kaminsky-Forrett, M-C.
Miroir, J.
Rolland, F.
Coutte, A.
Clatot, F.
Sinigaglia, L.
Thariat, J.
Even, C.
Saada, E. B.
Guigay, J.
Bourhis, J.
ANNALS OF ONCOLOGY, 2024, 35 : S616 - S616
[8] ACCELERATED RADIOTHERAPY AND/OR CONCOMITANT CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SCC: RESULTS OF A GORTEC RANDOMIZED TRIAL. (ON BEHALF OF THE GORTEC)
Bourhis, J.
Sire, C.
Lapeyre, M.
Gregoire, V.
Maingon, P.
Calais, G.
Martin, L.
Alfonsi, M.
Deprez, P.
Pignon, T.
Bardet, E.
Lusinchi, A.
Auperin, A.
RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S121 - S121
[9] Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial.
Bourhis, Jean
Auperin, Anne
Alfonsi, Marc
Sun, xu Shan
Rives, Michel
Pointreau, Yoann
Lafond, Cedrik
Boisselier, Pierre
Graff, Pierre
Thariat, Juliette
Tao, Yungan
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[10] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Husain, Zain A.
Burtness, Barbara A.
Decker, Roy H.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +

← 1 2 3 4 5 →